KENSTADA Trademark

Trademark Overview

On Monday, July 27, 2015, a trademark application was filed for KENSTADA with the United States Patent and Trademark Office. The USPTO has given the KENSTADA trademark a serial number of 86705290. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 30, 2022. This trademark is owned by Glaxo Group Limited. The KENSTADA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
kenstada

General Information

Serial Number86705290
Word MarkKENSTADA
Filing DateMonday, July 27, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 30, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 26, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 31, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Tuesday, May 31, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 30, 2022ABANDONMENT - NO USE STATEMENT FILED
Thursday, October 14, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 13, 2021SOU EXTENSION 5 GRANTED
Wednesday, October 6, 2021SOU EXTENSION 5 FILED
Wednesday, October 13, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 6, 2021SOU TEAS EXTENSION RECEIVED
Thursday, February 25, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 23, 2021SOU EXTENSION 4 GRANTED
Tuesday, February 23, 2021SOU EXTENSION 4 FILED
Tuesday, February 23, 2021SOU TEAS EXTENSION RECEIVED
Thursday, September 10, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 8, 2020SOU EXTENSION 3 GRANTED
Tuesday, September 8, 2020SOU EXTENSION 3 FILED
Tuesday, September 8, 2020SOU TEAS EXTENSION RECEIVED
Thursday, January 30, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 28, 2020SOU EXTENSION 2 GRANTED
Tuesday, January 28, 2020SOU EXTENSION 2 FILED
Tuesday, January 28, 2020SOU TEAS EXTENSION RECEIVED
Saturday, October 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 17, 2019SOU EXTENSION 1 GRANTED
Thursday, October 17, 2019SOU EXTENSION 1 FILED
Thursday, October 17, 2019SOU TEAS EXTENSION RECEIVED
Wednesday, October 16, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, October 16, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 23, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 26, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 26, 2019PUBLISHED FOR OPPOSITION
Wednesday, February 6, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, January 19, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 8, 2019SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, June 21, 2018REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, December 21, 2017REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, December 18, 2017ASSIGNED TO LIE
Saturday, June 10, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Saturday, June 10, 2017LETTER OF SUSPENSION E-MAILED
Saturday, June 10, 2017SUSPENSION LETTER WRITTEN
Friday, November 18, 2016REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, May 11, 2016REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, May 10, 2016ASSIGNED TO LIE
Saturday, November 7, 2015NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Saturday, November 7, 2015LETTER OF SUSPENSION E-MAILED
Saturday, November 7, 2015SUSPENSION LETTER WRITTEN
Thursday, November 5, 2015ASSIGNED TO EXAMINER
Friday, July 31, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 31, 2015NEW APPLICATION ENTERED

Related Keywords

kenstada pharmaceutical treatment preparations diseases disorders substances respiratory oncological genitourinary neurological